Market Research Report||Cancer Diagnostic Testing World Markets

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects. The goal of this Publications report is to review the market for tumor marker testing equipment and supplies using screening reagents and instruments for analysis of individual components in blood, serum or plasma.

Table of Contents :
1. Overview 8
1.1 Statement of Report 8
1.2 About This Report 8
1.3 Scope of the Report 9
1.4 Objectives 10
1.5 Methodology 10
1.6 Executive Summary 11

2. Introduction to Cancer Biology and the Diagnostic Industry 14
2.1 Cancer 14
2.1.1 The Disease 14
2.1.2 Metastasis 14
2.1.3 Demographics and Statistics of Cancer 14
2.2 The Drivers of the Biotech and Diagnostics Industry 19

3. Tumor Markers Market Segment Analysis: Size, Growth and Share 23
3.1 Market Description 24
3.2 Clinical Diagnostic Serum Based Cancer Markers 31
3.3 PSA Testing Market Size 32
3.4 DNA Markers 33
3.5 Serum Proteins 33
3.6 Enzymes 34
3.7 Occult Blood 34

4. Diagnostic Methods for Cancer Detection 59
4.1 Organ Specific Tumor Markers 59
4.1.1 Colon Cancer 59
4.1.2 Prostate Cancer 66
4.1.3 Pancreatic Cancer 83
4.1.4 Breast Cancer 85

For more information, please visit :

http://www.aarkstore.com/reports/Cancer-Diagnostic-Testing-World-Markets-1303.ht

Contact: Sanaa

Ph.No.91927282585

Tel. No. +912227453309

Email:jenniffer@aarkstore.com

URL:http://www.aarkstore.com/